top of page
Search

How Nations & Institutions Can Obtain their Select Nation Status (SNS) with FMTVDM® FRONTIER.

  • Writer: Richard M Fleming, PhD, MD, JD
    Richard M Fleming, PhD, MD, JD
  • Oct 26
  • 3 min read

Updated: Oct 27

A Roadmap for Licensing, Benefits, and the First-Mover Advantage


Introduction: The Global Healthcare Frontier Begins


Healthcare systems worldwide face a growing demand for technologies that move beyond subjective interpretation and provide quantified, reproducible measurements of disease and treatment response.


The Fleming Method for Tissue and Vascular Differentiation and Metabolism (FMTVDM®) provides exactly that—absolute quantification of physiological and metabolic changes in heart, cancer, and infectious disease in addition to other InflammoThrombotic Immunologic Response (ITIR) Diseases (ITIRDs) using standard SPECT or PET systems.


The 5-Year FMTVDM FRONTIER Plan (2025–2030) is now inviting select nations and institutions to lead this global transformation through the Select Nation Status (SNS) program.


What Is Select Nation Status (SNS)?


Select Nation Status (SNS) grants exclusive rights for a nation or regional institution to implement and license the FMTVDM® technology through January 1, 2030.


It is designed for ministries of health, national cancer centers, and major medical institutions seeking to establish quantitative imaging leadership.


Key SNS benefits include:


  • Exclusive national or regional licensing rights for FMTVDM® total-body imaging.

  • Priority access to technology transfer and certified training programs.

  • Membership in the FMTVDM Global Data Network to support evidence-based policy and research.

  • Early participation in the FMTVDM Academy for continuing professional education.

  • A formal position in the FMTVDM FRONTIER international collaboration (2025–2030).


Why Act Now?: The First-Mover Advantage


Only a limited number of SNS positions will be approved. Acting now ensures both national prestige and a long-term competitive advantage.


As the world shifts from qualitative image interpretation to quantitative medicine, early adopters will:


  • Set international standards for quantitative imaging.

  • Establish reproducible, data-driven national screening programs.

  • Train and license additional centers across their country or region.

  • Gain recognition as leaders in transparent, evidence-based medical innovation.


The Step-by-Step Roadmap to FMTVDM® Licensing


Step 1 — National or Institutional Briefing


Request an official FMTVDM® briefing for leadership teams to review published data, intellectual property, pilot design, and implementation structure.



Step 2 — Pilot Implementation


Select one center to begin the FMTVDM® FRONTIER pilot study under direct supervision, ensuring protocol accuracy and data reproducibility.


Step 3 — Training and Certification


Participate in the FMTVDM Academy for complete certification of scientists, physicians, medical physicists, and technologists—through both online and hands-on sessions.


Step 4 — National Scale-Up


Expand FMTVDM® implementation across certified centers nationwide, with ongoing quality assurance and integration into digital health networks as approved by FMTVDM FRONTIER.


Step 5 — Integration with the FRONTIER Plan


Join the FMTVDM FRONTIER Network, contributing to global data analysis, international publications, and healthcare policy development.


Concrete Benefits of FMTVDM® Adoption


  • Quantitative Imaging: Moves beyond subjective readings by providing measurable, reproducible data.

  • Early Detection: Identifies disease activity before structural changes or symptoms appear.

  • Precision Monitoring: Accurately measures therapeutic response across treatment regimens.

  • Data Integrity: Ensures consistency and transparency for clinical and research use.

  • Public Health Leadership: Demonstrates national commitment to evidence-based medicine and population wellness.


Peer-reviewed FMTVDM® research and supporting data are available at:




Licensing FAQ


Q: Who can apply for SNS?


Ministries of Health, national cancer or cardiology institutes, hospital systems, and academic medical centers.


Q: What is the timeline for implementation?


Most programs move from pilot to full implementation within 12–24 months.


Q: What does the certification include?


Comprehensive education through the FMTVDM Academy, including physics, nuclear medicine, image quantification, and data integration.


How to Apply


  • To request an official briefing or apply for Select Nation Status (SNS), contact:


📩 FMTVDM® International Coordination Office


  • The attached pdf provides a draft version for officials to complete and submit to the above email.




The Vision Ahead


Calibrated/Standardized and Quantitative imaging defines the next frontier in medicine—uniting physics, biology, and data science.


Through FMTVDM®, nations can move from assumption to measurement, from images to evidence, and from local practice to global precision medicine.


Be among the first to lead this transformation.

Quantify it with FMTVDM®.



The Official Path to Select Nation Status with FMTVDM FRONTIER


The FMTVDM® FRONTIER Plan links nations through Select Nation Status (SNS), establishing a global network for quantitative imaging and evidence-based healthcare leadership.
The FMTVDM® FRONTIER Plan links nations through Select Nation Status (SNS), establishing a global network for quantitative imaging and evidence-based healthcare leadership.


 
 
 

Comments


EMAIL FMTVDM FRONTIER
CONSORTIUM
DIRECTLY

Screenshot 2025-09-07 at 1.47.45 PM.png

FMTVDM FRONTIER INQUIRY

Multi-line address
Drawing mode selected. Drawing requires a mouse or touchpad. For keyboard accessibility, select Type or Upload.

© 2025 by Richard M Fleming, PhD, MD, JD.

Director, FMTVDM FRONTIER Consortium

Powered and secured by Wix

bottom of page